Effectiveness of alternative treatments for reducing potential viral contaminants from plasma-derived products

被引:45
作者
Chandra, S
Groener, A
Feldman, F
机构
[1] Aventis Behring, King Of Prussia, PA USA
[2] Aventis Behring GmbH, Marburg, Germany
关键词
D O I
10.1016/S0049-3848(02)00044-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An issue of great importance and continuing concern with regard to all products derived from human plasma is their safety from potential contaminants in the source material from which they are purified. Since viral contaminants are a major safety consideration with these products, a number of different methods, including dry heating, vapor heating, filtration and nanofiltration, ultraviolet and gamma irradiation, pasteurization, solvent/detergent (S/D) treatment, sodium thiocyanate treatment, and chromatography (immunoaffinity, metal chelation, affinity, and ion exchange), have been developed to remove or inactivate potentially contaminating viruses. Pasteurization and S/D treatment have emerged as the dominant viral inactivation methods. Results summarized in this review demonstrate that pasteurization is the broadest.. and most rigorous currently available method for removal of potential viral contaminants from plasma-derived products. S/D treatment requires control over a large number of manufacturing parameters and has no ability to inactivate nonlipid-enveloped viruses. Pasteurization requires control over only a small number of manufacturing variables, is easily monitored, and remains effective even if deviations are encountered from specified protein and stabilizer concentrations and temperature. In addition, pasteurization is effective against a wide range of lipid-and nonlipid-enveloped viruses. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:391 / 400
页数:10
相关论文
共 57 条
[11]  
BUSBY TF, 1981, J BIOL CHEM, V256, P2140
[12]   The removal of model viruses, poliovirus type 1 and canine parvorvirus, during the purification of human albumin using ion-exchange chromatographic procedures [J].
Cameron, R ;
Davies, J ;
Adcock, W ;
MacGregor, A ;
Barford, JP ;
Cossart, Y ;
Harbour, C .
BIOLOGICALS, 1997, 25 (04) :391-401
[13]   Virus reduction in the preparation of intravenous immune globulin: in vitro experiments [J].
Chandra, S ;
Cavanaugh, JE ;
Lin, CM ;
Pierre-Jerome, C ;
Yerram, N ;
Weeks, R ;
Flanigan, E ;
Feldman, F .
TRANSFUSION, 1999, 39 (03) :249-257
[14]  
CHANDRA S, 1999, DOWNSTREAM 31, P12
[15]   VIRUCIDAL SHORT-WAVELENGTH ULTRAVIOLET-LIGHT TREATMENT OF PLASMA AND FACTOR-VIII CONCENTRATE - PROTECTION OF PROTEINS BY ANTIOXIDANTS [J].
CHIN, S ;
WILLIAMS, B ;
GOTTLIEB, P ;
MARGOLISNUNNO, H ;
BENHUR, E ;
HAMMAN, J ;
JIN, RY ;
DUBOVI, E ;
HOROWITZ, B .
BLOOD, 1995, 86 (11) :4331-4336
[16]  
Chudy M, 1999, J MED VIROL, V57, P91, DOI 10.1002/(SICI)1096-9071(199902)57:2&lt
[17]  
91::AID-JMV1&gt
[18]  
3.0.CO
[19]  
2-L
[20]   TREATMENT OF INHERITED COAGULATION DISORDERS [J].
COHEN, AJ ;
KESSLER, CM .
AMERICAN JOURNAL OF MEDICINE, 1995, 99 (06) :675-682